Infective endocarditis in patients with kidney failure: Chronic dialysis and kidney transplant

Current Infectious Disease Reports

Volumn 5, Issue 4, 2003, Pages 293-299

  Ireland, James H E ^a   McCarthy, James T ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFTRIAXONE; GENTAMICIN; METICILLIN; NAFCILLIN; OXACILLIN; PENICILLIN G; PSEUDOMONIC ACID; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DEVICE REMOVAL; DIAGNOSTIC PROCEDURE; DIALYSIS; DISEASE ASSOCIATION; DRUG INDICATION; GRAM POSITIVE BACTERIUM; HEMODIALYSIS PATIENT; HUMAN; INFECTION RISK; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MORTALITY; MYCOSIS; PENICILLIN RESISTANCE; RECIPIENT; REVIEW; STAPHYLOCOCCUS AUREUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 3142702859     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-003-0005-y     Document Type: Review

References (54)

1. Lowance M: Subacute bacterial endocarditis, Streptococcus viridans, with mesenteric thrombosis and recovery. Ann Intern Med 1946, 24:485-487.
2. Dawson M: The treatment of subacute bacterial endocarditis with penicillin; second report. Ann Intern Med 1946, 46:170-185.
3. Cataldo R: Acute bacterial endocarditis; a case report with recovery after treatment with penicillin. Ann Intern Med 1946, 24:479-484.
4. Cabell CH, Jollis JG, Peterson GE, et al.: Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002, 162:90-94.
5. Maraj S, Jacobs LE, Shiang-Cheng K, et al.: Epidemiology and outcome of infective endocarditis in hemodialysis patients. Am J Med Sci 2002, 324:254-260.
6. McCarthy JT, Steckelberg JM: Infective endocarditis in patients receiving long-term hemodialysis. Mayo Clin Proc 2000, 75:1008-1014.
7. Robinson DL, Fowler VG, Sexton DJ, et al.: Bacterial endocarditis in hemodialysis patients. Am J Kidney Dis 1997, 30:521-524.
8. Herzog CA, Ma JZ, Collins AJ: Long-term survival of dialysis patients in the United States with bacterial endocarditis. (Abstract). J Am Soc Nephrol 2002, 13:439A.
9. Watanakunakorn C, Burkert T: Infective endocarditis at a large community teaching hospital. A review of 210 episodes. Medicine 1993, 72:90-102.
10. Bishara J, Robenshtok E, Weinberger M, et al.: Infective endocarditis in renal transplant recipients. Transplant Infect Dis 1999, 1:138-143.
11. Abbott KC, Duran M, Hypolite I, et al.: Hospitalizations for bacterial endocarditis after renal transplantation in the United States. J Nephrol 2001, 14:353-360.
12. Hanslik T, Flahault A, Vaillant JN, et al.: High risk of severe endocarditis in patients on chronic dialysis. Nephrol Dial Transplant 1997, 12:1301-1302.
13. Goodman JS, Crews HD, Ginn HE, Koenig MG: Bacterial endocarditis as a possible complication of chronic hemodialysis. N Engl J Med 1969, 280:876-877.
14. Nsouli KA, Lazarus M, Schoenbaum SC, et al.: Bacteremic infection in hemodialysis. Arch Intern Med 1979, 139:1255-1258.
15. U.S. Renal Data System: USRDS 2002 Annual Data Report. Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2002.
16. Descamps-Latscha B, Herbelin A, Nguyen AT, et al.: Immune system dysregulation in uremia. Semin Nephrol 1994, 14:253-260.
17. Abbott KC, Agodoa LY: Hospitalizations for valvular heart disease in chronic dialysis patients in the United States. Nephron 2002, 92:43-50.
18. Centers for Medicare and Medicaid Services: 2001 Annual Report, End Stage Renal Disease Clinical Performance Measures Project. Baltimore: Department of Health and Human Services, Centers for Medicare and Medicaid Services, Center for Beneficiary Choices; 2001.
19. Paterson DL, Dominguez EA, Chang FY, et al.: Infective endocarditis in solid organ transplant recipients. Clin Infect Dis 1998, 26:689-694.
20. Abbott KC, Agodoa LY: Etiology of bacterial septicemia in chronic dialysis patients in the United States. Clin Nephrol 2001, 56:124-131.
21. Marr KA, Kong L, Fowler VG, et al.: Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients. Kidney Int 1998, 54:1684-1689.
22. Hoen B, Paul-Dauphin A, Hestin D, Kessler M: EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998, 9:869-876.
23. Saad TF: Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 1999, 34:1114-1124.
24. Kessler M, Hoen B, Mayeux D, et al.: Bacteremia in patients on chronic hemodialysis. A multicenter prospective survey. Nephron 1993, 64:95-100.
25. Minga TE, Flanagan KH, Allon M. Clinical consequences of infected arteriovenous grafts in hemodialysis patients. Am J Kidney Dis 2001, 38:975-978.
26. Lentino JR, Baddour LM, Wray M, et al.: Staphylococcus aureus and other bacteremias in hemodialysis patients: antibiotic therapy and surgical removal of access site. Infection 2000, 28:355-360.
27. Saad TF: Central venous dialysis catheters: catheter-associated infection. Semin Dial 2001, 14:446-451.
28. Nielsen J, Kolmos HJ, Espersen F: Staphylococcus aureus bacteraemia among patients undergoing dialysis - focus on dialysis catheter-related cases. Nephrol Dial Transplant 1998, 13:139-145.
29. Spies C, Madison JR, Schatz IJ: Infective endocarditis in patients with end-stage renal disease: clinical presentation and outcome. Arch Intern Med 2003, In press.
30. Nassar GM, Ayus JC: Infectious complications of old nonfunctioning arteriovenous grafts in renal transplant recipients: a case series. Am J Kidney Dis 2002, 40:832-836.
31. Lisby G: Application of nucleic acid amplification in clinical microbiology. Mol Biotechnol 1999, 12:75-99.
32. Yang S, Lin S, Kelen GD, et al.: Quantitative multiprobe PCR assay for simultaneous dectection and identification to species level of bacterial pathogens. J Clin Microbiol 2002, 40:3449-3454.
33. Descheemaeker P, Ieven M, Chapelle S, et al.: Prevalence and molecular epidemiology of glycopeptide-resistant enterococci in Belgian renal dialysis units. J Infect Dis 2000, 181:235-241.
34. Wilson WR, Karchmer AW, Dajani AS, et al.: Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK organisms. JAMA 1995, 274:1706-1713.
35. Marr KA, Sexton DJ, Conlon PJ, et al.: Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997, 127:275-280.
36. Beathard GA: Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 1999, 10:1045-1049.
37. Lavelle KJ, Dentino MM: Surgical treatment of infective endocarditis in hemodialysis patients. Clin Nephrol 1978, 9:6-10.
38. Olaison L, Pettersson G: Current best practices and guidelines indications for surgical intervention in infective endocarditis. Infect Dis Clin North Am 2002, 16:453-475.
39. Sexton DJ, Spelman D: Current best practices and guidelines. Assessment and management of complications in infective endocarditis. Infect Dis Clin North Am 2002, 16:507-521.
40. Kaplon RJ, Cosgrove DM, Gillinov AM, et al.: Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival. Ann Thorac Surg 2000, 70:438-441.
41. Allon M, Robbin ML: Increasing arteriovenous fistulas in hemodialysis patients: Problems and solutions. Kidney Int 2002, 62:1109-1124.
42. Boelaert JR, Van Landuyt HW, Godard CA, et al.: Nasal mupirocin ointment decreases the incidence of Staphylococcus Aureus bacteremia in hemodialysis patients. Nephrol Dial Transplant 1993, 8:235-239.
43. Herwaldt LA: Reduction of Staphylococcus aureus nasal carriage and infection in dialysis patients. J Hosp Infect 1998, 40(Suppl B):S13-S23.
44. Werner CW, Saad TF: Prophylactic antibiotic therapy prior to dental treatment for patients with end-stage renal disease. Spec Care Dent 1999, 19:106-111.
45. De Rossi SS, Glick M: Dental considerations for the patient with renal disease receiving hemodialysis. J Am Dent Assoc 1996, 127:211-219.
46. Levison ME, Abrutyn E: Infective endocarditis: current guidelines on prophylaxis. Curr Infect Dis Rep 1999, 1:119-125.
47. Little J: The American Heart Association's guidelines for the prevention of bacterial endocarditis: a critical review. Gen Dent 1998, 46:508-515.
48. Raad I, Darouiche R, Dupuis J, et al.: Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. Ann Intern Med 1997, 127:267-274.
49. Trerotala SO, Johnson MS, Shah H, et al.: Tunneled hemodialysis catheters: use of a silver-coated catheter for prevention of infection - a randomized study. Radiology 1998, 207:491-496.
50. Aronoff GR, Berns JS, Brier ME, et al.: Drug Prescribing in Renal Failure. Dosing Guidelines for Adults, edn 4. Philadelphia: American College of Physicians; 1999.
51. Veremis SA, Maddux MS, Pollak R, et al.: Subtherapeutic cyclosporine concentrations during nafcillin therapy. Transplantation 1987, 43:913-915.
52. Jahansouz F, Kriett JM, Smith CM, et al.: Potentiation of cyclosporine nephrotoxicity by nafcillin in lung transplant recipients. Transplantation 1993, 55:1045-1048.
53. Alverez J, Sacristan Del Castillo JA, Alsar Ortiz MJ: Interaction between cyclosporin and ceftriaxone [letter]. Nephron 1991, 59:681-682.
54. Finch CK, Chrisman CR, Baciewicz AM, Self TH: Rifampin and rifabutin drug interactions. Arch Intern Med 2002, 162:985-992.